No Detail Found!

Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab

Author(s)
Ferhat Ekinci Department of Medical Oncology, Manisa Celal Bayar University, Manisa, Turkey
Atike Pinar Erdogan Department of Medical Oncology, Manisa Celal Bayar University, Manisa, Turkey
Serkan Yildirim Department of Medical Oncology, Baskent University, Konya Application and Research Centre, Konya, Turkey
Gulcan Bulut Department of Medical Oncology, International Medicana Hospital, Izmir, Turkey
Cengiz Yilmaz Department of Medical Oncology, Bozyaka Training and Research Hospital, Izmir, Turkey
Sabri Barutca Department of Medical Oncology, Aydın Adnan Menderes University, Aydın, Turkey
Abstract
Objective: To evaluate the utility of inflammatory prognostic index (IPI), albumin, c-reactive protein (CRP), and lactate dehydrogenase (LDH) as predictive biomarkers of oncologic outcome in metastatic renal cell cancer (mRCC) patients treated with nivolumab. Study Design: Descriptive study. Place and Duration of Study: Manisa Celal Bayar University, Ayd1n Adnan Menderes University, Bitlis Tatvan State Hospital and Private Hatay Defne Hospital Medical Oncology Clinics, Turkey, from January 2017 to June 2020. Methodology: Seventy- ve mRCC patients treated with nivolumab between January 2017 and June 2020 were enrolled. Several factors were retrospectively investigated, including IPI, CRP, LDH, and albumin level, for their association with progression-free survival (PFS) and overall survival (OS). The IPI was calculated as CRP × NLR/albumin. Univariate and multivariate analyses were performed to assess the prognostic value of relevant factors. Results: When analysed according to the calculated IPI score, it is seen that the group with <2.153 has an OS duration of 96.3 months, while the group with e2.153 has a shorter time of 42.9 months (p=0.02). In the analysis performed according to albumin level, it was reported that those with low levels (22.8 months) had worse median OS than those with high levels (92.8 months) (p=0.004). According to the cox regression analysis results, it was determined that those with a high IPI score signi cantly increased the risk of death compared to those with a low score (HR:2.4, p=0.023). However, this signi cance could not be con rmed in the multivariate analysis. It was analysed that those with low albumin levels signi cantly increased the risk of death compared to both univariate analysis (HR:3.3, p=0.007) and multivariate analysis (HR:4.4, p=0.003). Conclusion: Those with high IPI scores and low albumin levels were associated with worse median OS. However, only the multivariate analysis analysed albumin level as an independent prognostic variable. Prospective and more extensive research is needed to consolidate the potential prognostic power of these markers.
Publication Details
Page(s) 1288-1294
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 10, Year: 2022

Request the full text from PASTIC

Keywords
albumin, overall survival, Progression-free survival, IPI score, Immune checkpoint inhibitor, Nivolumab, Metastatic renal cell carcinoma
0

Citations

0

Downloads

96

Views